ENA-001 for Opioid Induced Respiratory Depression

Clinical trial NCT06967259 · RECRUITING

Trial details

NCT number: NCT06967259
Sponsor: Enalare Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Depression

Start date: 2025-05-14
Primary completion: 2026-07-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.